Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: Spain,Russian Federation,France,Estonia,Finland,Korea, Republic of,Romania,Ukraine,Italy
nct
Update Il y a 5 ans
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
The objective of the current study is to investigate the safety and efficacy of BI 10773 in 2 different doses compared to Metformin or to Sitagliptin given for 78 weeks in different modalities of treatment in patients with type 2 diabetes mellitus.
Country
Austria
,
Croatia
,
Czech Republic
,
Estonia
,
Finland
,
France
,
Germany
,
Hungary
,
Italy
,
Korea, Republic of
,
Latvia
,
Lithuania
,
Norway
,
Romania
,
Russian Federation
,
Slovakia
,
Spain
,
Sweden
,
Taiwan, Province of China
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1